- Halma reported an adjusted pretax profit of GBP270.5 million for the first half of the year, marking a 29% increase compared to the same period last year, and outperforming the estimate of GBP239 million.
- Revenue reached GBP1.24 billion, up 15% year-over-year, surpassing the forecast of GBP1.17 billion.
- The Environmental & Analysis sector’s revenue soared by 35% to GBP488.2 million, beating the expected GBP428.2 million.
- Medical sector revenue rose by 6.6% to GBP286.8 million, higher than the projected GBP277.7 million.
- The Safety sector saw a 4.1% revenue growth, reaching GBP463.1 million, compared to the estimate of GBP455.5 million.
- There was a minor intersegment revenue loss of GBP0.7 million.
- Adjusted earnings per share (EPS) increased to 55.32p, up from 43.01p the previous year, exceeding the prediction of 50.76p.
- An interim dividend of 9.63p per share has been declared.
- Looking ahead, the company sees an adjusted EBIT margin of 22%, previously expecting the high end of a 19% to 23% range.
- Guidance has been increased, now anticipating fiscal year mid-teens percentage organic constant currency revenue growth, with notable contributions from the photonics segment.
- From analysts, there are 10 buy ratings, 8 hold ratings, and 2 sell ratings.
Halma PLC on Smartkarma
Analyst coverage of Halma PLC on Smartkarma reveals positive sentiments and in-depth evaluations by top independent analysts:
Baptista Research‘s analysis focuses on Halma plc’s recent full-year financial results, emphasizing the company’s 22nd consecutive year of profit growth. The research delves into the company’s diversified portfolio across Safety, Environmental & Analysis, and Healthcare sectors. Baptista Research aims to assess various factors that could impact the company’s future stock price, carrying out an independent valuation using a Discounted Cash Flow (DCF) methodology.
On the other hand, αSK‘s report highlights Halma’s decentralized business model, which nurtures nearly 50 technology companies to maintain leadership in specialized global niches. The analysis applauds the company’s strong financial performance, consistent revenue and profit growth, and a remarkable 46-year streak of annual dividend increases. αSK underscores Halma’s presence in resilient end markets with secular growth drivers, such as safety regulations, healthcare demands, and sustainability focus, positioning the company for sustained future growth.
A look at Halma PLC Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 2 | |
| Dividend | 2 | |
| Growth | 4 | |
| Resilience | 3 | |
| Momentum | 5 | |
| OVERALL SMART SCORE | 3.2 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Halma PLC, a health and safety sensor technology group, has a promising long-term outlook based on the Smartkarma Smart Scores. With a strong momentum score of 5, the company shows robust growth potential in the foreseeable future. Additionally, Halma scores high in growth with a score of 4, indicating positive prospects for expansion and development. This suggests that the company is well-positioned to capitalize on opportunities in the market and drive sustainable growth over time.
Furthermore, Halma demonstrates solid resilience with a score of 3, reflecting its ability to weather challenges and uncertainties. Although the value and dividend scores are not as high, at 2 each, the company’s overall outlook remains positive due to its focus on innovation and market momentum. In summary, Halma PLC‘s strategic focus on health and safety technology positions it favorably for long-term success in the evolving market landscape.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
